Influenza

Troy Trygstad spoke with MD Magazine ® about the potential for a pandemic flu and emphasized that there’s no “crystal ball” to help predict this.

These mistakes can be as simple as a worker touching their face before removing contaminated gloves.

Troy Trygstad spoke with MD Magazine® about the upcoming flu season and emphasized how different clinicians and parts of the healthcare system can play a role in promoting immunization.

After a high-volume flu season driven by outbreak of the mutated H3N2 strain, Sanofi has bolstered its vaccine class with options specific to older populations.

A study of pediatric patients with asthma admitted to emergency departments has determined that while rhinovirus is the most prevalent infection, it is the non-rhinovirus pathogens that are associated with an increased absolute risk of treatment failure.

The antiviral treatment for patients at high risk of complications from influenza met the primary objective of efficacy measured by time to improvement of symptoms compared to placebo.

If approved, this would be the first oral, 1-dose antiviral and the first medicine with a novel proposed mechanism of action to treat the flu in about 20 years.

Between 60-80% of pediatric asthma exacerbations are triggered by respiratory pathogens. For most children, the common cold is the culprit.

If approved, the same 0.5 mL dose vaccination can be used with all patients ages 6 months and older for whom flu vaccination is recommended.

“Original antigenic sin" is the result of slight year-to-year virus change that are not caught by antibodies produced by the body during previous vaccinations.

Representatives from NIAID and St. Jude Children's Research Hospital dispel exaggerations on the current flu outbreak.

The influenza vaccine can now be used to protect recommended persons aged 6 months and older.

Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (NIAID), shared with MD Magazine what the main theme would be in his keynote address at the AAAAI 2017 meeting in Atlanta, GA: emerging and reemerging infections, a perpetual challenge.

As flu strains evolve each year, the latest vaccine guidelines have changed for the 2016 to 2017 season.

The degree to which the influenza vaccine protects patients from the virus depends on their ethnic background and other inherited factors.

A retrospective analysis of records from more than 55,000 patients indicates that influenza infection increases the risk of developing atrial fibrillation (AF) and that increased vaccination could reduce AF onset.

Heads up Broncos and Panthers fans! You might want to load up on the vitamin C and hand sanitizer.

It’s prime time for runny noses, sore throats, and just overall not feeling well. But if you’re taking medicine for a pesky cough, do not take Licorice Coughing Liquid.

Men better start loading up on vitamin C because new research says that women are already naturally protected against the flu.

When most people think of vaccines their first thought is often the flu shot. For many patients, especially older patients there are other conditions to consider as well.

Although there was widespread circulation of influenza viruses that were antigenically drifted from the vaccine virus, last year's flu vaccine appears to have been effective in preventing severe illness requiring hospitalization.

ID Week is the most relevant and important meeting for ID as a whole.

Not all flu virus strains are created equal. After all, some are better equipped to transmit from host to host than others and new research has pinpointed an intricate factor that allows the virus to do so through the air.

The debate over whether influenza vaccines are valuable in elderly patients may be put to end as a study from Brown University has verified that the strategy has made a positive impact.

A dissolvable microneedle patch provides just as much protection against the flu as typical needle delivered vaccines, according to researchers from Osaka University.